Skip to main content

Wild new cancer treatment attacks tumors with drug-filled, magnetically-guided bubbles

Micro-bubbles anticancer drugs
Creative Commons

A new method of delivering anticancer drugs may help bypass some of the damaging effects of chemotherapy. Using magnetic micro-bubbles and ultrasonic vibrations, scientists have been able to transport and deploy drugs deep into tumor cells.

The scientists developed magnetic micro-bubbles, which were covered with magnetic nanoparticles, which were embedded with anti-cancer drugs. They injected this whole concoction into the bloodstreams of laboratory mice. The magnetization enabled scientists to steer the micro-bubbles towards tumors and, with ultrasound vibrations, maneuver them towards the tumor’s vulnerable area. Added ultrasound vibrations caused the bubbles to explode, shooting anticancer drug-carrying nanoparticles 50 cell layers deep or hundreds of micrometers into tumor tissue.

Recommended Videos

In a paper published in the journal Nature, scientists Chenjie Xu and Claus-Dieter Ohl of Nanyang Technological University (NTU Singapore) say, “Targeted drug delivery and controlled release is the ‘holy grail’ of nanomedicine.” That’s because chemotherapy drugs are indiscriminate, damaging both cancerous and healthy cells as they flow through the bloodstream. A drug’s effectiveness is also compromised once it’s absorbed and filtered by the liver and lungs. What’s left of the anticancer drug has limited effects on the tumor itself, as it’s unable to infiltrate into the tissue. The cancer cells that remain alive can multiply and cause resurgence of the disease.

Last month, Chinese and American researchers developed another innovative method to address targeted drug deliver and controlled release. With nanoparticle “cluster bombs,” a team led Jun Wang, Shuming Nie, et al. were able to sneak into tumor tissue and release chemotherapy medicine directly inside the cells. The three-staged process sees relatively large nanoparticles travel through the bloodstream, slip into the tumor’s leaky blood vessels, and discharge anticancer “bomblets” which infiltrate and attack the tumor cells. With methods like these, cancer cells can run and hide but they’ll be tracked, infiltrated, and assassinated.

Dyllan Furness
Former Digital Trends Contributor
Dyllan Furness is a freelance writer from Florida. He covers strange science and emerging tech for Digital Trends, focusing…
Aptera’s 3-wheel solar EV hits milestone on way toward 2025 commercialization
Aptera 2e

EV drivers may relish that charging networks are climbing over each other to provide needed juice alongside roads and highways.

But they may relish even more not having to make many recharging stops along the way as their EV soaks up the bountiful energy coming straight from the sun.

Read more
Ford ships new NACS adapters to EV customers
Ford EVs at a Tesla Supercharger station.

Thanks to a Tesla-provided adapter, owners of Ford electric vehicles were among the first non-Tesla drivers to get access to the SuperCharger network in the U.S.

Yet, amid slowing supply from Tesla, Ford is now turning to Lectron, an EV accessories supplier, to provide these North American Charging Standard (NACS) adapters, according to InsideEVs.

Read more
Yamaha offers sales of 60% on e-bikes as it pulls out of U.S. market
Yamaha Pedal Assist ebikes

If you were looking for clues that the post-pandemic e-bike market reshuffle remains in full swing in the U.S., look no further than the latest move by Yamaha.

In a letter to its dealers, the giant Japanese conglomerate announced it will pull out of the e-bike business in the U.S. by the end of the year, according to Electrek.

Read more